Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Krajewska J, Jarząb M, Czarniecka A, Roskosz J, Kukulska A, Handkiewicz-Junak D, Puch Z, Wygoda Z, Paliczka-Cieślik E, Kropińska A, Gubała E, Jurecka-Lubieniecka B, Jarząb B. Krajewska J, et al. Endokrynol Pol. 2016;67(1):2-11. doi: 10.5603/EP.2016.0001. Endokrynol Pol. 2016. PMID: 26884109 Free article.
Managing tyrosine kinase inhibitors side effects in thyroid cancer.
Krajewska J, Paliczka-Cieslik E, Jarzab B. Krajewska J, et al. Among authors: paliczka cieslik e. Expert Rev Endocrinol Metab. 2017 Mar;12(2):117-127. doi: 10.1080/17446651.2017.1300526. Epub 2017 Mar 8. Expert Rev Endocrinol Metab. 2017. PMID: 30063430
Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma.
Krajewska J, Jarzab M, Kukulska A, Czarniecka A, Roskosz J, Puch Z, Wygoda Z, Paliczka-Cieslik E, Kropinska A, Krol A, Handkiewicz-Junak D, Jarzab B. Krajewska J, et al. Among authors: paliczka cieslik e. Nucl Med Mol Imaging. 2019 Oct;53(5):320-327. doi: 10.1007/s13139-019-00608-8. Epub 2019 Sep 5. Nucl Med Mol Imaging. 2019. PMID: 31723361 Free PMC article.
Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer.
Ledwon A, Paliczka-Cieślik E, Syguła A, Olczyk T, Kropińska A, Kotecka-Blicharz A, Hasse-Lazar K, Kluczewska-Gałka A, Jarząb B, Handkiewicz-Junak D. Ledwon A, et al. Among authors: paliczka cieslik e. Ann Nucl Med. 2021 Nov;35(11):1214-1222. doi: 10.1007/s12149-021-01663-y. Epub 2021 Aug 7. Ann Nucl Med. 2021. PMID: 34363597 Free PMC article.
Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomes.
Kukulska A, Krajewska J, Gawkowska M, Paliczka-Cieslik E, Handkiewicz-Junak D, Kropińska A, Puch Z, Olczyk T, Roskosz J, Jarzab B. Kukulska A, et al. Among authors: paliczka cieslik e. Arch Med Sci. 2020 Aug 3;18(5):1241-1247. doi: 10.5114/aoms.2020.97803. eCollection 2022. Arch Med Sci. 2020. PMID: 36160333 Free PMC article.
13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study.
Handkiewicz-Junak D, Roskosz J, Hasse-Lazar K, Szpak-Ulczok S, Puch Z, Kukulska A, Olczyk T, Piela A, Paliczka-Cieslik E, Jarzab B. Handkiewicz-Junak D, et al. Thyroid Res. 2009 Aug 1;2(1):8. doi: 10.1186/1756-6614-2-8. Thyroid Res. 2009. PMID: 19646277 Free PMC article.
18 results